Replies to post #31744 on Marker Therapeutics Inc (MRKR)

[GoIrish1776]

I believe the REGAL trial is more akin to the adjuvant arm of the MRKR PII. Also, I’m not sure why they both couldn’t be used together but that’s a much broader question, long-term question.

The SLS folks on Y! are tough to stomach.